MediciNova Receives New Patent Covering MN-029 (denibulin) di ...
The allowed claims cover a compound, pharmaceutical composition and method of treating certain cell proliferation diseases, including solid tumors, based on denibulin di-hydrochloride. MediciNova intends to use denibulin ... MediciNova, Inc. is a ...
GlobeNewswire (press release) - Thu, 29 Jan 2015 14:52

The Small-Cap Biotech Watchlist 2015 Unwrapped: Who Are These Guys? And ...
Peregrine's Phase 3 candidate is bavituximab, a phosphatidylserine-targeting antibody in a Phase 3 clinical trial as a second-line therapy in non-small cell lung cancer (in combination with docetaxel). Bavituximab has shown, in preclinical studies ...
CountingPips (blog) - Tue, 27 Jan 2015 20:07

Symphogen Regains Rights to Sym004
The trials are a Phase 2b study in patients with metastatic colorectal cancer (mCRC) and a Phase 1b study in patients with Non-Small Cell Lung Cancer (NSCLC). In addition, a Japanese Phase 1 study, which started in 2013, is currently recruiting ...
Yahoo Finance UK - Thu, 29 Jan 2015 01:00

Lymphoseek® Performance vs. Sulfur Colloid in Breast Cancer Patients ...
It is a novel, receptor-targeted, small-molecule radiopharmaceutical used in the evaluation of lymphatic basins that may have cancer involvement in patients. Lymphoseek is designed for the precise identification of lymph nodes that ... Lymphoseek has ...
Business Wire (press release) - Thu, 29 Jan 2015 04:22

Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue
Thermal therapies are unique treatment modalities typically applied as monotherapies (without repetition) thereby denying cancer cells the opportunity to express defensive mutations. Further, the destructive mechanisms of action involved with ...
Nature.com - Tue, 27 Jan 2015 03:14

Moffitt Cancer Center Researchers Develop Novel Approach to Visualize ...
They focused their study on the epidermal growth factor receptor (EGFR) that is often mutated or expressed at high levels in many tumor types, including non-small cell lung cancer, head and neck squamous cell carcinoma, and renal cell carcinoma.
HealthCanal.com - Wed, 14 Jan 2015 06:37

Joe Paterno Fast Facts
January 22, 2012 - Dies of metastatic small cell carcinoma of the lung at Mount Nittany Medical Center in State College at the age of 85. June 22, 2012 - Former Penn State assistant football coach Jerry Sandusky is found guilty on 45 of 48 counts ...
4029tv - Mon, 26 Jan 2015 08:09

Anti-PD-1 Drug Improves Survival in NSCLC, Trial Halted
A study of nivolumab (Opdivo, Bristol-Myers Squibb) compared with docetaxel in patients with squamous cell non-small-cell lung cancer (NSCLC) was stopped early after an interim analysis showed superiority of the study drug. The study was conducted in ...
Cancer Network - Wed, 21 Jan 2015 12:26


<-   1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014